MMSI

Merit Medical Systems, Inc. NASDAQ

Healthcare ·Medical - Instruments & Supplies ·US · merit.com

$60.44

Pre-mkt $60.80 +0.60%

Mkt Cap $3.6B

52w Low $60.26 0.5% of range 52w High $100.19

50d MA $70.16 200d MA $81.22

P/E (TTM) 28.6x

EV/EBITDA 17.1x

P/B 2.3x

Debt/Equity 0.6x

ROE 8.1%

P/FCF 24.2x

RSI (14) —

ATR (14) —

Beta 0.65

50d MA $70.16

200d MA $81.22

Avg Volume 732.8K

About

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in per…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 30, 2026	AMC	0.84	0.94	+11.9%	68.18	-1.7%	-9.0%	-9.0%	-11.4%	—	—	—
Feb 24, 2026	AMC	0.96	1.04	+8.3%	82.43	+1.6%	-3.9%	-5.3%	-6.4%	-7.2%	-9.2%	—
Oct 30, 2025	AMC	0.82	0.92	+12.2%	83.04	+7.0%	+5.4%	+5.2%	+6.5%	+4.9%	+4.2%	—
Jul 30, 2025	AMC	0.86	1.01	+17.4%	82.96	+2.2%	+2.3%	+2.2%	+2.9%	+1.8%	+0.7%	—
Apr 24, 2025	AMC	0.75	0.86	+14.8%	94.67	-3.9%	-0.1%	+0.8%	+0.1%	-0.2%	-1.6%	—
Feb 25, 2025	AMC	0.82	0.93	+13.4%	102.03	-3.4%	-1.5%	-3.5%	+0.0%	+1.0%	-0.1%	—
Oct 30, 2024	AMC	0.80	0.86	+7.5%	94.90	+1.2%	+4.0%	+4.1%	+4.4%	+4.1%	+8.0%	—
Aug 1, 2024	AMC	0.88	0.92	+4.5%	84.12	+3.5%	+5.5%	+3.9%	+6.5%	+5.4%	+8.0%	—
Apr 30, 2024	AMC	0.71	0.77	+8.5%	74.10	+0.8%	+3.4%	+3.9%	+6.6%	+7.3%	+8.6%	—
Feb 28, 2024	AMC	0.77	0.81	+5.2%	80.13	+1.3%	-4.9%	-4.8%	-4.5%	-6.3%	-6.6%	—
Oct 26, 2023	AMC	0.65	0.75	+15.4%	63.49	+5.5%	+8.7%	+4.7%	+8.3%	+11.9%	+11.2%	—
Jul 25, 2023	AMC	0.75	0.81	+8.0%	81.53	-4.3%	-11.1%	-11.2%	-9.8%	-8.4%	-9.2%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 1	Needham	Maintains	Buy → Buy	—	$68.18	$67.00	-1.7%	-9.0%	—	—	—	—
May 1	Canaccord Genuity	Maintains	Buy → Buy	—	$68.18	$67.00	-1.7%	-9.0%	—	—	—	—
May 1	JP Morgan	Maintains	Overweight → Overweight	—	$68.18	$67.00	-1.7%	-9.0%	—	—	—	—
May 1	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$68.18	$67.00	-1.7%	-9.0%	—	—	—	—
Apr 20	Barrington Research	Maintains	Outperform → Outperform	—	$70.93	$70.56	-0.5%	-1.6%	-4.3%	-1.7%	-3.3%	-3.3%
Apr 17	Piper Sandler	Maintains	Overweight → Overweight	—	$70.10	$70.83	+1.0%	+1.2%	-0.4%	-3.2%	-0.5%	-2.1%
Apr 7	Canaccord Genuity	Maintains	Buy → Buy	—	$67.81	$67.36	-0.7%	-0.6%	+2.1%	+1.2%	+0.7%	+4.1%
Apr 1	Needham	Maintains	Buy → Buy	—	$68.93	$69.45	+0.8%	-1.0%	-1.8%	-1.6%	-2.2%	+0.4%
Feb 26	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$79.23	$78.28	-1.2%	-1.5%	-2.6%	-3.4%	-5.5%	-6.4%
Feb 25	Barrington Research	Maintains	Outperform → Outperform	—	$82.43	$83.76	+1.6%	-3.9%	-5.3%	-6.4%	-7.2%	-9.2%
Feb 25	Needham	Maintains	Buy → Buy	—	$82.43	$83.76	+1.6%	-3.9%	-5.3%	-6.4%	-7.2%	-9.2%
Feb 18	Piper Sandler	Maintains	Overweight → Overweight	—	$81.59	$81.09	-0.6%	+1.7%	+0.3%	+0.8%	+0.0%	+1.0%
Jan 9	Needham	Maintains	Buy → Buy	—	$93.18	$91.61	-1.7%	-7.3%	-10.7%	-13.0%	-12.3%	-13.8%
Dec 17	Canaccord Genuity	Maintains	Buy → Buy	—	$86.85	$86.85	+0.0%	+0.4%	+0.7%	+1.0%	+1.2%	+0.9%
Nov 14	Wells Fargo	Maintains	Overweight → Overweight	—	$87.40	$80.03	-8.4%	-2.6%	-1.8%	-3.7%	-4.2%	-2.9%
Nov 14	Barrington Research	Maintains	Outperform → Outperform	—	$87.40	$80.03	-8.4%	-2.6%	-1.8%	-3.7%	-4.2%	-2.9%
Nov 14	Canaccord Genuity	Maintains	Buy → Buy	—	$87.40	$80.03	-8.4%	-2.6%	-1.8%	-3.7%	-4.2%	-2.9%
Oct 31	Needham	Maintains	Buy → Buy	—	$83.04	$88.86	+7.0%	+5.4%	+5.2%	+6.5%	+4.9%	+4.2%
Oct 31	Barrington Research	Maintains	Outperform → Outperform	—	$83.04	$88.86	+7.0%	+5.4%	+5.2%	+6.5%	+4.9%	+4.2%
Oct 31	Piper Sandler	Maintains	Overweight → Overweight	—	$83.04	$88.86	+7.0%	+5.4%	+5.2%	+6.5%	+4.9%	+4.2%
Oct 16	Canaccord Genuity	Maintains	Buy → Buy	—	$80.47	$81.62	+1.4%	+0.4%	+1.7%	+3.4%	+4.6%	+5.0%
Oct 7	Barrington Research	Maintains	Outperform → Outperform	—	$83.31	$83.93	+0.7%	-0.7%	+0.5%	-1.0%	-5.2%	-4.7%
Sep 23	Barrington Research	Maintains	Outperform → Outperform	—	$83.59	$83.54	-0.1%	+0.2%	-0.6%	-4.2%	-4.1%	-3.3%
Jul 31	Wells Fargo	Maintains	Overweight → Overweight	—	$82.96	$84.75	+2.2%	+2.3%	+2.2%	+2.9%	+1.8%	+0.7%
Jul 31	Piper Sandler	Maintains	Overweight → Overweight	—	$82.96	$84.75	+2.2%	+2.3%	+2.2%	+2.9%	+1.8%	+0.7%
Jul 31	Barrington Research	Maintains	Outperform → Outperform	—	$82.96	$84.75	+2.2%	+2.3%	+2.2%	+2.9%	+1.8%	+0.7%
Jul 31	Raymond James	Maintains	Outperform → Outperform	—	$82.96	$84.75	+2.2%	+2.3%	+2.2%	+2.9%	+1.8%	+0.7%
Jul 18	Needham	Maintains	Buy → Buy	—	$84.54	$85.32	+0.9%	-1.8%	-0.7%	-0.1%	+0.6%	-0.4%
Jul 8	Needham	Maintains	Buy → Buy	—	$91.12	$93.75	+2.9%	+4.6%	+5.4%	+4.4%	+2.6%	+2.6%
May 23	Piper Sandler	Maintains	Overweight → Overweight	—	$95.11	$93.86	-1.3%	+0.3%	+1.5%	-0.7%	-0.3%	-0.1%
May 21	Wells Fargo	Maintains	Overweight → Overweight	—	$98.81	$98.07	-0.7%	-2.3%	-3.7%	-3.5%	-2.3%	-4.4%
May 21	Canaccord Genuity	Maintains	Buy → Buy	—	$98.81	$98.07	-0.7%	-2.3%	-3.7%	-3.5%	-2.3%	-4.4%
May 20	Needham	Maintains	Buy → Buy	—	$98.10	$98.30	+0.2%	+0.7%	-1.6%	-3.0%	-2.8%	-1.6%
May 15	Needham	Maintains	Buy → Buy	—	$97.01	$96.76	-0.3%	+0.6%	+1.9%	+1.1%	+1.9%	-0.5%
Apr 25	Baird	Maintains	Outperform → Outperform	—	$94.67	$91.00	-3.9%	-0.1%	+0.8%	+0.1%	-0.2%	-1.6%
Apr 25	Needham	Maintains	Buy → Buy	—	$94.67	$91.00	-3.9%	-0.1%	+0.8%	+0.1%	-0.2%	-1.6%
Apr 25	Barrington Research	Maintains	Outperform → Outperform	—	$94.67	$91.00	-3.9%	-0.1%	+0.8%	+0.1%	-0.2%	-1.6%
Apr 25	Raymond James	Maintains	Outperform → Outperform	—	$94.67	$91.00	-3.9%	-0.1%	+0.8%	+0.1%	-0.2%	-1.6%
Apr 25	Piper Sandler	Maintains	Overweight → Overweight	—	$94.67	$91.00	-3.9%	-0.1%	+0.8%	+0.1%	-0.2%	-1.6%
Apr 25	Canaccord Genuity	Maintains	Buy → Buy	—	$94.67	$91.00	-3.9%	-0.1%	+0.8%	+0.1%	-0.2%	-1.6%
Apr 25	Wells Fargo	Maintains	Overweight → Overweight	—	$94.67	$91.00	-3.9%	-0.1%	+0.8%	+0.1%	-0.2%	-1.6%
Apr 23	Piper Sandler	Maintains	Overweight → Overweight	—	$91.45	$92.24	+0.9%	+2.5%	+3.5%	+3.5%	+4.4%	+3.6%
Apr 11	Barrington Research	Maintains	Outperform → Outperform	—	$91.54	$90.95	-0.6%	+0.5%	+1.9%	+0.5%	-1.1%	-0.7%
Apr 9	Needham	Maintains	Buy → Buy	—	$88.48	$87.47	-1.1%	+8.3%	+3.5%	+4.0%	+5.4%	+3.9%
Feb 26	Barrington Research	Maintains	Outperform → Outperform	—	$102.03	$98.53	-3.4%	-1.5%	-3.5%	+0.0%	+1.0%	-0.1%
Feb 26	Needham	Maintains	Buy → Buy	—	$102.03	$98.53	-3.4%	-1.5%	-3.5%	+0.0%	+1.0%	-0.1%
Feb 26	Canaccord Genuity	Maintains	Buy → Buy	—	$102.03	$98.53	-3.4%	-1.5%	-3.5%	+0.0%	+1.0%	-0.1%
Feb 26	Wells Fargo	Maintains	Overweight → Overweight	—	$102.03	$98.53	-3.4%	-1.5%	-3.5%	+0.0%	+1.0%	-0.1%
Jan 29	Needham	Maintains	Buy → Buy	—	$109.03	$110.07	+1.0%	-0.5%	+1.2%	-0.1%	-1.6%	-0.9%
Jan 29	Piper Sandler	Maintains	Overweight → Overweight	—	$109.03	$110.07	+1.0%	-0.5%	+1.2%	-0.1%	-1.6%	-0.9%

Recent Filings

8-K · 7.01 ! Medium

Unknown — 8-K 7.01: Regulation FD Disclosure

Merit Medical disclosed additional revenue breakdown details but signaled it won't repeat this transparency going forward, likely disappointing investors seeking ongoing visibility into product-line performance.

Apr 13

8-K · 7.01 ! Medium

Unknown — 8-K 7.01: Regulation FD Disclosure

Merit Medical disclosed forward-looking statements with risk warnings, suggesting upcoming material announcements that may significantly impact stock performance, warranting careful monitoring for competitive, regulatory, or operational developments.

Apr 1

8-K · 7.01 ! Medium

Merit Medical Systems Inc -- 8-K 7.01: Regulation FD Disclosure

Merit Medical Systems will host a February 24, 2026 earnings call to discuss Q4 2025 and full-year 2025 results, with live webcast access available.

Feb 24

8-K · 5.02 !!! Very High

Baxter International Inc. -- 8-K 5.02: Executive Change

Baxter International appointed Michael R. McDonnell as Executive Vice President effective February 13, 2026, signaling internal leadership development and potential changes to executive responsibilities.

Feb 12

Data updated apr 26, 2026 12:43pm · Source: massive.com